136 related articles for article (PubMed ID: 16612063)
1. Hemoglobinopathy control program in Turkey.
Canatan D; Kose MR; Ustundag M; Haznedaroglu D; Ozbas S
Community Genet; 2006; 9(2):124-6. PubMed ID: 16612063
[TBL] [Abstract][Full Text] [Related]
2. Thalassemias and hemoglobinopathies in Turkey.
Canatan D
Hemoglobin; 2014; 38(5):305-7. PubMed ID: 25030194
[TBL] [Abstract][Full Text] [Related]
3. Report on Ten Years' Experience of Premarital Hemoglobinopathy Screening at a Center in Antalya, Southern Turkey.
Canatan D; Delibas S
Hemoglobin; 2016 Aug; 40(4):273-6. PubMed ID: 27207683
[TBL] [Abstract][Full Text] [Related]
4. Premarital hemoglobinopathy screening in Kayseri: a city in Middle Anatolia region of Turkey.
Karakukcu C; Kocer D; Altuner Torun Y; Karakukcu M; Yokus O; Ozdemir MA; Patiroglu T
J Pediatr Hematol Oncol; 2012 Mar; 34(2):e49-52. PubMed ID: 22246155
[TBL] [Abstract][Full Text] [Related]
5. Premarital hemoglobinopathy screening program results of a province in the Black Sea region of Turkey: three years' experience.
Ozdemır S; Oruc MA; Yazıcıoglu B; Turkan S
Postgrad Med; 2023 Nov; 135(8):818-823. PubMed ID: 38019185
[TBL] [Abstract][Full Text] [Related]
6. Preliminary data on preimplantation genetic diagnosis for hemoglobinopathies in Turkey.
Zeren F; Genç A; Cürük MA
Hemoglobin; 2007; 31(2):273-7. PubMed ID: 17486511
[TBL] [Abstract][Full Text] [Related]
7. [Hemoglobinopathies in Tunisia. An updated review of the epidemiologic and molecular data].
Fattoum S
Tunis Med; 2006 Nov; 84(11):687-96. PubMed ID: 17294892
[TBL] [Abstract][Full Text] [Related]
8. Genetic Blood Disorders Survey in the Sultanate of Oman.
Al-Riyami A; Ebrahim GJ
J Trop Pediatr; 2003 Jul; 49 Suppl 1():i1-20. PubMed ID: 12934793
[TBL] [Abstract][Full Text] [Related]
9. Premarital screening test results for β-thalassemia and sickle cell anemia trait in east Mediterranean region of Turkey.
Guler E; Garipardic M; Dalkiran T; Davutoglu M
Pediatr Hematol Oncol; 2010 Nov; 27(8):608-13. PubMed ID: 20795773
[TBL] [Abstract][Full Text] [Related]
10. Thalassaemia screening in a non-prevalent region of a prevalent country (Turkey): is it necessary?
Acemoglu H; Beyhun NE; Vancelik S; Polat H; Guraksin A
Public Health; 2008 Jun; 122(6):620-4. PubMed ID: 18222509
[TBL] [Abstract][Full Text] [Related]
11. Steps toward the prevention of hemoglobinopathies in the kingdom of Saudi Arabia.
Al-Shahrani M
Hemoglobin; 2009; 33 Suppl 1():S21-4. PubMed ID: 20001628
[TBL] [Abstract][Full Text] [Related]
12. The Frequency and Distribution Pattern of ß-Thalassemia Mutations in Turkey.
Altay Ç
Turk J Haematol; 2002 Jun; 19(2):309-15. PubMed ID: 27264774
[TBL] [Abstract][Full Text] [Related]
13. Screening for thalassemia and other hemoglobinopathies in a tertiary care hospital of West Bengal: implications for population screening.
Jain BB; Roy RN; Ghosh S; Ghosh T; Banerjee U; Bhattacharya SK
Indian J Public Health; 2012; 56(4):297-300. PubMed ID: 23354142
[TBL] [Abstract][Full Text] [Related]
14. Premarital hemoglobinopathy screening in Kocaeli, Turkey: a crowded industrial center on the north coast of Marmara Sea.
Sarper N; Şenkal V; Güray F; Şahin Ö; Bayram J
Turk J Haematol; 2009 Jun; 26(2):62-6. PubMed ID: 27265274
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of hemoglobinopathies in the state of Orissa, India: a ten years cohort study.
Balgir RS
J Assoc Physicians India; 2005 Dec; 53():1021-6. PubMed ID: 16572956
[TBL] [Abstract][Full Text] [Related]
16. Analysis of thalassemia syndromes and abnormal hemoglobins in patients from the Aegean region of Turkey.
Irken G; Oren H; Undar B; Duman M; Gülen H; Uçar C; Sanli N
Turk J Pediatr; 2002; 44(1):21-4. PubMed ID: 11858374
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of beta-thalassemia and sickle cell anemia trait in premarital screening in Konya urban area, Turkey.
Guler E; Caliskan U; UcarAlbayrak C; Karacan M
J Pediatr Hematol Oncol; 2007 Nov; 29(11):783-5. PubMed ID: 17984699
[TBL] [Abstract][Full Text] [Related]
18. A National Registry of Thalassemia in Turkey: Demographic and Disease Characteristics of Patients, Achievements, and Challenges in Prevention.
Aydınok Y; Oymak Y; Atabay B; Aydoğan G; Yeşilipek A; Ünal S; Kılınç Y; Oflaz B; Akın M; Vergin C; Sezgin Evim M; Çalışkan Ü; Ünal Ş; Bay A; Kazancı E; İleri T; Atay D; Patıroğlu T; Kahraman S; Söker M; Akcan M; Akdeniz A; Büyükavcı M; Alanoğlu G; Bör Ö; Soyer N; Özdemir Karadaş N; Uysalol E; Türker M; Akçay A; Ocak S; Güneş AM; Tokgöz H; Ünal E; Tiftik N; Karakaş Z
Turk J Haematol; 2018 Mar; 35(1):12-18. PubMed ID: 28404539
[TBL] [Abstract][Full Text] [Related]
19. Hemoglobinopathies in the district of Antalya, Turkey.
Bircan I; Sişli S; Güven A; Cali S; Yeğin O; Ertuğ H; Güven AG; Akar N
Pediatr Hematol Oncol; 1993; 10(3):289-91. PubMed ID: 8217548
[TBL] [Abstract][Full Text] [Related]
20. Comparing prenatal and neonatal diagnosis of hemoglobinopathies.
Schoen EJ; Marks SM; Clemons MM; Bachman RP
Pediatrics; 1993 Sep; 92(3):354-7. PubMed ID: 8361789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
